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malignancy is less well defined than for the myeloid counterparts. 
Between Jan 83 and Sept 02, 86 such patients (pts) proceeded to 
allogeneic HSCT at the Leukemia/BMT Program of BC. Diag- 
noses (dx) included ALL in 37 (12 Ph+), NHL  in 27 (2 special- 
Burkitt's or lymphoblastic lymphoma; 14 aggressive or trans- 
formed; 11 indolent), CLL in 3, PLL in 1, and myeloma in 18 pts. 
Median (reed) age was 36 (range 12-53) yrs; 52 (60%) were male. 
Med interval dx to HSCT was 9.7 mos (range 1.6 mos to 14.7 yrs). 
Disease status was intermediate or advanced in the majority (7I 
pts, 83%). Donors were mmrd in 14 cases (1 Ag mm in 13, 2 Ag 
mm in 1 pt), and UD in 72 pts (1 Ag mm in 14 pts, 2 Ag mm in 1, 
the remainder HLA matched). Stem cell source was marrow in the 
majority (n=82, 95%); peripheral blood (pb) alone in 2 cases and 
pb + marrow in 2. Conditioning included TBI for most (79pts, 
92%). GVHD prophylaxis was CSP + MTX +/- other for 71 
(82%); T-cell depletion was employed in I2 cases (14%). Engraft- 
ment  (range) of ANC > 0.Sx109/L; WBC > I.OxlOp/L and 
platelets > 20xlO9/L; occurred a reed of 19 (9-33); 20 (9-32); and 
27 (6-124) days respectively. Graft failure occurred in 4 pts. Inci- 
dence of acute GVHD grades II-W; III-1V and chronic GVHD 
was 74%; 46%; and 76%. Thirty-three pts (38%) survive a reed of 
3.6 yrs (range 1 mo - 12 yrs) post HSCT. Fifty three pts (62%) 
are deceased, 19 with relapse (REL) a reed of 353 days and 34 
with non-relapse mortality (NRM) a med of 66 days post HSCT. 
For NRM deaths, GVHD contributed in 21 pts, infection in 7 
including 3 cases of EBV assoc LPD, and RRT in 6 (5 puhn, 1 
VOD) to the cause of death. Four patients have sustained avascu- 
lar necrosis of large joints. Cumulative incidence estimates of 
NRM; REL; EFS and OS are 42%; 31%; 28% and 31%. In con- 
clusion: 1. About 1/3 of pts with lymphoid malignancies receiving 
HSCT from alternative donors achieved long-term survival, with 
the lead pts out more than 10 years. 2. The incidence of relapse is 
reasonable but still significant in this cohort where 'graft vs malig- 
nancy' would be expected to be strongly operative. 3. GVHD and 
infection remain challenging problems in this setting. 
127 
COMBINATION SIROLIMUS AND TACROLIMUS IMMUNOPROPHYLAXIS 
PROMOTES ENGRAFTMENT OF HAPLOIDENTICAL AND ALTERNATIVE 
DONOR STEM CELLS WITH NON-MYELOABLATIVE CONDITIONING IN 
ELDERLY AND POOR PROGNOSIS PATIENTS 
Claxto~, D.F.; Popesclf, D.; Kopp, 31.; Ebmaml, C.; Rybka, ~ Medi- 
ci*~e/Hem-OJzc, PeJzJz State College of Med, He'J',~'hey 3h'dical Cezzte'v, 
Hershey, PA. 
Between 4/2001 and 8/2002 16 patients 44-72 years old (median 
63) received non-ablative stem cell transplantation with Sirolimus 
(Siro) + Tacrolimus (Tacro) immunoprophy]axis. Diagnoses were: 
AML - 8, NHL  - ~, ALL - 1, CML/Philadelphia negative - 1, and 
CLL-1. Patients had failed 1-5 chemotherapy regimens. All 
received Fludarabine 25rag/m2 d-7 to -3 and Cyclophosphamide 
1 gin/m2 d-7 and -6. Siro began d-7 and Tacro d-3. Both were 
targeted to 5-10ng/lnl. SCT was dO and MTX 5rag/m2 dl, 3 and 
6. Patients with 3/6 or 4/6 matched donors received ATG d-l, 1, 
3, and 5. Patient-donor matches were: 6 -5/6 HLA matched, 3 - 
4/6 matched, 2 3/6 matched, 4 matched unrelated donors - all 
peripheral SCT. One received 4/6 matched cord blood cells. Sur- 
vival at 100-days was 86.66% (i3/I5). Overall survival was 62.5% 
(10/16 Pts, median follow-up d184). The cord blood recipient 
died d26 without stable engraftment. 4 of 5 patients with 3/6 or 
4/6 matched onors died, d37 (cerebrovascular ccident), d32 and 
d158 (coinplications of GVHD). Two died of leukemia d170 and 
d119. All others remain alive including one with a 4/6-matched 
donor -d315. 11/12 (91.6%) alive at day 100 had >95% donor 
engrafunent. One 5/6 matched recipient had only transient donor 
chimerism but recovered with autologous cells. 15/16 patients 
achieved ANC >500/ul (d5-19, median dl0.) 14/16 patients 
achieved platelets >50, 000/ul (d10-60, median dis  - in 2 platelets 
were never <50, 000/uh) Most patients developed elevated creati- 
nine - Max 0.7 to 6.Smg/dl (median 2.95mg/dl). No dialysis was 
required, but creatinine >2.Smg/dl d40-150 prompted withdrawal 
of Tacro in 5 patients. Three had Tacro withdrawn per protocol 
because of risk of relapse. In only one has Tacro tapering clearly 
resulted in GVHD (grade 2, skin). Max cholesterol was 122-527 
mg/dl (median 295.5 mg/dI) and triglyccrides 123-1366mg/dl 
(median 427mg/dl). Drug levels had no correlation with renal or 
lipid toxicities or engraftment. GVHD was: none -4 pts, grade 2 
in 11, grade 3 in I by day 100. Tacro l imus and Sirol imus 
immunoprophylaxis yields relatively effective engraftment in eld- 
erly and poor prognosis patients receiving alternative and hap- 
loidentical donor stem cell transplautation. 
IMMUNE RECONSTITUTION 
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RECONSTITUTION OF NR CELL RECEPTOR REPERTOIRE FOLLOWING 
HLA-MATCHED HEMATOPOIETIC CELL TRANSPLANTATION 
M,'Qztee77, K.L.S; Shillillg, H.G. 1; Ctae1~g, N. ~K 1; Shiszcl'zl, a%4. ~-; 
Negri~z, R.S.2; Pa~qJa711, P. i I. Structm'al Biolow , Sta*lffbrd U11ive*si~, 
Sta,TJb~vt, CA; 2. Dept of MediciT~e, Sta,gbrd, C4. 
The interactions between killer immunoglobulin-like r ceptors 
(KIR) and their human leukocyte antigen (HLA) class I ligands 
are important for NK cell functions and evelopment of NK cell 
receptor repertoires. The fact that both KIR and HLA class I, 
encoded on separate chromosomes, are highly polymorphic pre- 
dicts that the majority of hematopoietic cell transplantations will 
be KIR-mismatched. Consequently, we have used allogeneic 
transplantation as a tool to examine development of NK cell 
receptor epertoires under conditions of KIR and/or I ILA differ- 
ence. Eighteen leukemia patients receiving transplants and their 
donors were analyzed for KIR genotype. Ten  of 13 HLA- 
matched sibling transplants were K/R mismatched while three 
were matched. All unrelated transplants were K/R-mismatched. 
Reconstitution of NK receptor epertoire was examined follow- 
ing t ransplantat ion by flow cytometry using KIR and 
CD94:NKG2A-speeif ic monoclonal antibodies. Three distinct 
patterns of reconstitution were observed. Eight patients reconsti- 
tuted NK cell repertoires like that of the donor and distinct from 
the recipient within the first year post-transplantation. I  con- 
trast, five patients exhibited a generally depressed frequency of 
KIR-expressing NK cells, while CD94:NKG2A expression 
remained high during the first year post transplantation. In three 
of these patients analyzed three years post-transplant, the fre- 
quency of KiR-expressing NK cells had increased to donor lev- 
els. The remaining five patients experienced severe clinical com- 
pl ications fol lowing transplantat ion and displayed unique 
patterns of reconstitution. These results demonstrate that KIR- 
mismatch occurs in the majority of H/~/-matched hematopoietic 
cell transplants and that most patients reconsitute donor-type 
KIR phenotypes. Prelimina W results fi'om a larger study to exam- 
ine the impact of K/R-mismatch on transplant outcome will be 
presented. 
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ENHANCED T-CELL NEOGENESIS FOLLOWING NON-MYELOABLATIVE 
ADULT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTA- 
TION (NM-HSCT) 
Hochl, eJ'g, E.P. 7; Levi~z, J.A. 1; ,41yea, E.P. 1; A~th~, ff.H. 1; Soiff~v, 
R.ff. 1; Rit~, 57.1 1. Medk'al O~zcolo©,, DaTza Favl, ev Calzc'er blstitz~te, 
Boston1, M/l; 2. BJ'igham alld T'VomeT~ ;" Hospital, Bostoll, MA. 
Measurements of T ceil reconstitution after adult allogencic 
hematopoietic stem cell transplant provide early biologic corre- 
lates for the clinical endpoints of fimctional inmmnity and disease 
free smwivah Quantitative PCR for T cell receptor excision circles 
(TREC) is an accurate measurement of the generation of new T 
cells from undifferentiated hematopoietic stem cells and thus pro- 
vides an assessment of thymic function in vivo. Previous studies 
have shown that myeloablative regimens markedly reduce thymic 
output of new T cells for 6-9 months following allogeneic trans- 
plant. Moreover, reduced levels of TREC correlate with decreased 
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T cell repertoire and the presence of opportunistic nfectious post 
transplant. Thymic fimction may be preselwed in patients who 
receive reduced intensity preparative regimens leading to 
enhanced T cell neogenesis following transplant. Alternatively, 
the presence of mixed hematopoietic/13qnphoid chimerism follow- 
ing non-nayeloablative regimens may adversely impact thymic 
function. To examine these alternatives we examined reconstitu- 
tion of TREC in 12 patients who received a NM-HSCT from 
HLA-identical siblings or unrelated onors. The conditioning 
regimen consisted of fludarabine (30 mg/m2/day x 4) and IV 
busulfan (0.8 mg/kg/day x 4). GVHD prophylaxis consisted of 
prednisone and cyclosporine. Only 20% of patients developed 
transient neutropenia (ANC <500/all) following transplant. Mixed 
hematopoietic chimerism was established in all patients. TREC 
were measured by quantitative PCR in genomic DNA extracted 
from PBMC prior to transplant and then at the 1, 3, 6 and 12 
month time points. TREC values decreased by 1.5 logs 1 month 
post transplant and recovered to pre-transplant levels at 3 and 6 
months after transplant. In contrast to recovel T after myeloabla- 
tive regimens, TREC values remained higher after NM-HSCT 
and no patients had undetectable TREC values. These results 
indicate that thymic function is preserved after reduced intensity 
conditioning and that T cell neogenesis remains relatively intact 
following transplant. Further studies will examine the influence of 
chimerism and GVHD on TREC recovery. These observations 
support he hypothesis that T cell function reconstitutes more 
rapidly in patients who receive allogeneic hematopoietic stem cells 
following non-myeloablative conditioning. 
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FUNCTIONAL ANALYSES OF CYTOMEGALOVIRUS-SPECIFIC LONG- 
TERM MEMORY EFFECTOR CELLS 
Kod,~e, G.; T~/ved/, D.; ~V///hm~s, R.K; O'Rdlly, N.J. Al/oge~dc Bo~e 
3/Iavvow T~:a~stdm~tatio~, 3/[emorial Sloa~-k~'tte~'i~g Ca~cev Ce~te~, 
New York, NK 
Expression of CCR7 and CD45RA have recently been used for 
sub-classifications of"memory T cells. CCR7+CD45RA-CD8+ lym~ 
phocytes, central memory cel]s, lacking immediate effector ftmetion, 
develop into CCRT-CD45RA-CD8+ cells upon secondary stinrula- 
tion, termed effector memory cells. Subsequendy, these cells can fur- 
ther develop into a CCR7-CD45RA+ cell subset. I  is speculated that 
these ceils are ten~ainally differentiated, finally u dergoing apoptosis. 
~,'Vhen we analyze cytomegalovin~s (CMV) peptide-specific T cells 
of HLA-A*0201+, seropositive donors, stained and isolated with 
MHC tetranaers complexed withA*0201-restricted NLVPMVATV 
epitope, we demonstrate in 3 CMV+/A*0201+ donors tested that 
>90% of the MHC-tewamer+ T-cell population iscontained within 
the CCRT-CD45RA+ memou-cell subset. All of these cells stained 
positively for intracellular perforin, whereas none of the CCR7 
expressing CD8+ cells stained positive for perforin. We purified the 
CCRT-CD45RA+ memory-cell subset (>95% purity by ilmnunoab- 
sorption) and found that we enriched the NLVPMVATV-peptide 
specific T-cell population by 2-3 fold (up to 12 % ofMHC tetramer+ 
cells) within the isolated cell fraction compared to 1-4% oftetramer+ 
cells within the non-purified CDS+ cell-population. Although the 
isolated CCR7-CD45RA+ contained 12% of NLVPMVATV-epi-  
tope specific T cells and all cells stained positive f r intracellular per- 
forin, these ceils failed to lyse or to produce intracellular IFN-y in 
response to peptide pulsed K562 cells, transduced to xpress A*0201 
(K562/A*0201) or CMV infected MRC-5 fibroblasts. However, 
when these cells were stimulated with NLVPMVATV-pulsed 
monocyte-derived dendritic ells for 10 dayg and re-analyzed, the T 
cells generated were now CCR7-CD45RA-, of which 98% were 
MHC-tetramer+. Furthermore, 89% p'roduced intracellular [FN-y 
in response to stimulation withpeptide pulsed K562/A*0201 and 
11% in response to CMV-infected MRC-5 fibroblasts. These results 
therefore suggest that CCR7-CD45RA+ ceils are not terminally dif- 
ferentiated and can give rise to highly functional effector cells, pro- 
vided these cells are re-activated and converted to CD45RA- effector 
memory cells. Isolation of CCRT-CD45RA+ T-cell populations may 
offer a new approach for the rapid selection and generation ofvirai- 
antigen specific T cells, since multiple epitope-specific T cells may 
be contained within this memory T-cell pool. 
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T CELL FUNCTION AND CYTORINES IN AUTOLOGOUS PBSC 
TRANSPLANTATION: COMPARATIVE ANALYSIS OF IMMUNE CELL 
POPULATIONS WITHIN THE PBSC GRAFT VS BLOOD POST 
TRANSPLANT 
GoldlJla77, F.D.; B,%Ttl~2d, L.; TbompsoJ~, A.; SilveTwla~, 3~I. Umversi- 
t~' o[Iowa Cbihl're11~ Ho~7~iml , Ioz~a d~'O, , L4. 
Prompt imnmne reconstitution has been noted in autologous 
peripheral blood stem cell (PBSC) transplant recipients, perhaps 
related to increased number of T cells and higher cytokine levels 
in the PBSC graft relative to marrow. Currently it is unknown 
whether qualitative and/or quantitative characteristics of the 
PBSC graft influence subsequent imnmne reconstitution post 
transplant. To address this, we analyzed various immune parame- 
ters of the PBSC product and compared this to peripheral blood 
from the same patients early post transplant. Five patients were 
studied within 1-2 months post transplant, having recovered from 
the acute toxicity of the myeloablative therapy. Innnunopheno- 
typing was performed on fresh peripheral blood or thawed cells 
from the PBSC product using a panel of monoclonal ntibodies to 
assess T, B, NK cells, and T cell subsets. T ceil antigen receptor 
(TCR) signaling was assessed by measuring upregulation of sur- 
face activation markers CD69 and CD25 post anti-CD3 stimula- 
tion. Thl and Th2 cytokines were quantitated by real time PCR, 
measuring basal and anti-CD3 stimulated mRNA levels of IL-2, 
IL-4, IL-5 and IFN7. Of note, the PBSC product contained 0-3 % 
B cells, similar to that seen post transplant, W~hile NK ceils 
accounted for 8-I2% of the graft, this was the predominant cell 
type early post transplant. T cells (CD4 and CD8) were the pre- 
dominant cell type in the PBSC graft, accounting for nearly 75% 
of the total lymphocytes. While the CD4:8 ratio and 
CD45RA:RO ratio was shnilar in the pre and post transplant set- 
ting, a relative decrease in T cell numbers was noted post trans- 
plant.TCR-mediated responses (CD25 and CD69 upregulation) 
were intact in the PBSC product, and somewhat decreased in the 
post transplant setting. IFN 7 was markedly elevated in the blood 
post transplant (16 fold increase) relative to levels noted in the 
PBSC graft. Similarly, IL-2 and IL-4 levels were also increased 
(2-4 fold) post transplant. In conclusion, the imnmnophenotype 
of the PBSC graft did not correlate with that noted in the periph- 
eral blood early post transplant. Furthernaore, the finding of umd- 
erately intact TCR-mediated responses and increased Thl  and 
Th2 cytokines uggests that T cells appearing early post PBSC 
transplant are functional and capable of mediating immune 
responses. 
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THE T LYMPHOCYTE RESPONSE TO ASPERGILLUS (ASP) RESULTS IN 
RAPID TNF-cc, IFN-7 AND IL-2 INTRACELLULAR CYTOKINE (ICC) 
PRODUCTION AND CAN OCCUR WITHOUT APCS 
Hearse/, N.; EL Has, rap, I.; Ba~v'ett, ,7, Ste111 Cell A/logelzeic Tl'a1~splal~- 
tatioJ7 SectioJ~, Hell~ntolo©, B1vT~ch, NHLBI, Natio~zLI1 b~stitzttes of" 
Health, DHHS, Bethe.rchT, 3lID. 
\¥e studied T cell responses to aspergillus to develop ossible 
immunotherapy strategies to treat invasive aspergillosis after allo- 
geneic stem cell transplant. T cell responses to Asp were evaluat- 
ed using PBMC obtained by apheresis from healthy volunteers. 
Heat-killed, irradiated, sonicated hyphae and conidia of Aspergillm" 
f'a~1dg~tlls were used as antigens. Intracellular production of IL-2, 
IL-4, IL-5, IL-10, IL-13, TNF-0~ and IFN-¥ by CD4 and IL-2, 
TNF-ct and IFN- 7 by CD8 cells was measured by flow cytome- 
try. Proliferation responses was measured by 5-day tritiated 
thymidiffe incorporation. T cell responses were further character- 
ized using a panel of 21 TCR V~ mouoclonal antibodies. The 
predominant cytoldnes detected after a 6-hour exposure to Asp 
cotiidia aud hyphae were IL-2, IFN-7 and TNF-ct. Normal sub- 
jects were tested by ICC. See TABLE. Proliferation to conidia 
and hyphae was tested in 15 leukapheresis samples. Stimulation 
indices (S]) varied from 2-30 (hyphae) and 3-18 (conidia). TCR
V[} analysis showed expansion in CD4 and CD8 T cells. The V[3 
profile after 5-day stimulation showed preferential expansion of 
V135.2, 11, 13.6 and 23, independent of HLA type. We next 
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